Press Release
May 12, 2022

Germitec raises €11 million in financing round

The Paris Life Sciences and Technology team advised Germitec, a global healthcare leader in high-Level UV-C disinfection systems, on a financing round of €11 million.

Reference investors in the healthcare sector, Financière Arbevel, Kurma Partners, via its Kurma Growth Opportunities fund, and Sham Innovation Santé advised by Turenne Capital, become GERMITEC shareholders. Private investors and Southwest regional funds (Aquiti Gestion, via its NACO fund, and Galia Gestion) also join this financing round.

The main objective of this new financing round is to launch an ambitious international commercial expansion plan.

The Goodwin team was led by Anne-Charlotte Rivière and included Marie Fillon and Louis de Chezelles on IP aspects, as well as Marie-Laure Bruneel on tax aspects.